|
| 34675406 | Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. | Oncogene | 2022 |
| 35978719 | GM-CSF antibodies in artificial stone associated silicoproteinosis: A case report and literature review. | Respirol Case Rep | 2022 |
| 35331963 | NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma. | J Thorac Oncol | 2022 |
| 33453471 | Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival. | Lung Cancer | 2021 |
| 32562873 | A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. | J Thorac Oncol | 2020 |
| 33035778 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Lung Cancer | 2020 |
| 32593449 | RE: Spread Through Air Spaces (STAS) is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung. | J Thorac Oncol | 2020 |
| 30572031 | Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. | J Thorac Oncol | 2019 |
| 31668406 | Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer. | Pathology | 2019 |
| 31522515 | Endobronchial metastases from hepatocellular carcinoma: a case report. | Asian Cardiovasc Thorac Ann | 2019 |
| 31050216 | Immunocytochemistry for predictive biomarker testing in lung cancer cytology. | Cancer Cytopathol | 2019 |
| 30348992 | Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer. | Oncogene | 2019 |
| 28686497 | Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society. | Arch Pathol Lab Med | 2018 |
| 29800747 | PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project. | J Thorac Oncol | 2018 |
| 30206043 | Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System. | Clin Lung Cancer | 2018 |
| 30142389 | Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma. | J Thorac Oncol | 2018 |
| 30089579 | Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review. | Lung Cancer | 2018 |
| 29367758 | The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53. | Oncogene | 2018 |
| 29127023 | Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung. | J Thorac Oncol | 2018 |
| 28613913 | Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society. | Arch Pathol Lab Med | 2018 |
| 27625078 | Impact of sex on prognostic host factors in surgical patients with lung cancer. | ANZ J Surg | 2017 |
| 28105777 | Lung cancer and socio-economic status: inextricably linked to place of residence. | Intern Med J | 2017 |
| 28420726 | Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung Cancer. | Clin Cancer Res | 2017 |
| 28343542 | Is Mesothelioma in China Rare or Misdiagnosed? | J Thorac Oncol | 2017 |
| 29088766 | Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. | Oncotarget | 2017 |
| 28811082 | Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients. | Pathology | 2017 |
| 28879441 | EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma. | Med Oncol | 2017 |
| 28777143 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. | Adv Anat Pathol | 2017 |
| 28777142 | Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. | Adv Anat Pathol | 2017 |
| 28611104 | Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma. | Mol Cancer Ther | 2017 |
| 28891180 | De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer. | Intern Med J | 2017 |
| 27998793 | The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases. | J Thorac Oncol | 2017 |
| 28074012 | Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer. | Sci Signal | 2017 |
| 26118394 | Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours. | Histopathology | 2016 |
| 26496089 | Electromagnetic Navigation Bronchoscopy-directed Pleural Tattoo to Aid Surgical Resection of Peripheral Pulmonary Lesions. | J Bronchology Interv Pulmonol | 2016 |
| 27696931 | Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma. | Expert Rev Anticancer Ther | 2016 |
| 27306574 | Nodular pulmonary light chain deposition disease. | Pathology | 2016 |
| 27177600 | Changing trends in diagnosis, staging, treatment and survival in lung cancer: comparison of three consecutive cohorts in an Australian lung cancer centre. | Intern Med J | 2016 |
| 27020204 | Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations. | Pathology | 2016 |
| 26744530 | IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis. | Cancer Res | 2016 |
| 26855952 | Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail? | Ann Transl Med | 2016 |
| 27000594 | Defining Measures of Quality in Lung Cancer Diagnosis and Staging. | Ann Thorac Surg | 2016 |
| 25789833 | Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer. | J Thorac Oncol | 2015 |
| 26488015 | The promise of lung master protocol for squamous cell carcinoma: one trial to rule them all, one trial to find them⿦? | Ann Transl Med | 2015 |
| 26168399 | Comprehensive genomic profiles of small cell lung cancer. | Nature | 2015 |
| 25650807 | Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. | Genome Biol | 2015 |
| 24469108 | CD74-NRG1 fusions in lung adenocarcinoma. | Cancer Discov | 2014 |
| 25191746 | Genomic characterisation of small cell lung cancer patient-derived xenografts generated from endobronchial ultrasound-guided transbronchial needle aspiration specimens. | PLoS One | 2014 |
| 25173427 | Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer. | Nat Med | 2014 |
| 24742923 | Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine. | Oncotarget | 2014 |